Application 219088
- Type
- ANDA
- Sponsor
- AUROBINDO PHARMA LIMITED
Application Products#
| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|---|---|---|---|---|---|
| 001 | UBROGEPANT | UBROGEPANT | TABLET | 100MG | No | No |
| 002 | UBROGEPANT | UBROGEPANT | TABLET | 50MG | No | No |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| UBRELVY | UBROGEPANT | Allergan, Inc. | fd9f9458-fd96-4688-be3f-f77b3d1af6ab | 2025-06-05 | Warnings, Adverse reactions | UBROGEPANT |